Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 399, Iss. 10320, pp. 143-151
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 526
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100794-100794
Open Access | Times Cited: 262
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 400, Iss. 10349, pp. 359-368
Open Access | Times Cited: 254
Understanding COVID-19-associated coagulopathy
Edward M. Conway, Nigel Mackman, Ronald Q. Warren, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 639-649
Open Access | Times Cited: 246
ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.
Nature (2022) Vol. 605, Iss. 7908, pp. 146-151
Open Access | Times Cited: 135
Therapeutic advances in COVID-19
Naoka Murakami, Robert Hayden, Thomas Hills, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 38-52
Open Access | Times Cited: 128
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
Simin Florescu, Delia Stanciu, Mihaela Zaharia, et al.
JAMA (2022) Vol. 327, Iss. 13, pp. 1247-1247
Open Access | Times Cited: 108
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19
Jeffrey S. Berger, Lucy Z. Kornblith, Michelle N. Gong, et al.
JAMA (2022) Vol. 327, Iss. 3, pp. 227-227
Open Access | Times Cited: 105
Platelets amplify endotheliopathy in COVID-19
Tessa J. Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Science Advances (2021) Vol. 7, Iss. 37
Open Access | Times Cited: 101
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Norberto Perico, Monica Cortinovis, Fredy Suter, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e22-e33
Open Access | Times Cited: 66
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 3, pp. 190-200
Open Access | Times Cited: 14
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT
Erin A. Bohula, David D. Berg, Mathew S. Lopes, et al.
Circulation (2022) Vol. 146, Iss. 18, pp. 1344-1356
Open Access | Times Cited: 65
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
Geoffrey D. Barnes, Allison Burnett, Arthur L. Allen, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 2, pp. 197-210
Open Access | Times Cited: 54
Thromboinflammation: From Atherosclerosis to COVID-19
Denisa D. Wagner, Lukas Andreas Heger
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 9, pp. 1103-1112
Open Access | Times Cited: 53
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19
Jonathan H. Chow, Ali Rahnavard, Mardi Gomberg‐Maitland, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e223890-e223890
Open Access | Times Cited: 52
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Maryam Al‐Nesf, Houari Abdesselem, Ilham Bensmail, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 49
Thromboinflammation in acute injury: infections, heatstroke, and trauma
Toshiaki Iba, Julie Helms, Marcel Levi, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 1, pp. 7-22
Closed Access | Times Cited: 36
Microvascular Thrombosis as a Critical Factor in Severe COVID-19
Patricia P. Wadowski, Benjamin Panzer, Alicja Józkowicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2492-2492
Open Access | Times Cited: 25
Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study
Pyry N. Sipilä, Joni V. Lindbohm, G. David Batty, et al.
Circulation (2023) Vol. 147, Iss. 21, pp. 1582-1593
Open Access | Times Cited: 25
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 12, pp. 905-914
Open Access | Times Cited: 21
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study
Geneviève Cézard, Rachel Denholm, Rosemary Knight, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top